불임 치료 서비스 시장 보고서 : 불임 원인, 시술, 서비스, 최종사용자, 지역별(2024-2032년)

The global fertility services market size reached US$ 40.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 129.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.3% during 2024-2032.

Fertility services refer to the procedures provided as a treatment for infertility. Infertility is defined as the inability to conceive or carry a full-term pregnancy. Among males, it is identified by a low sperm count or is a result of hormonal imbalance in men. For females, infertility refers to the lack of proper functioning of glands such as hypothalamus and pituitary gland that stimulate hormones in the brain to trigger the ovaries to release an egg. Fertility treatments include medications and procedures that increase the chances of pregnancy. They involve fertility drugs, artificial insemination, In Vitro Fertilization (IVF), egg-freezing or oocyte cryopreservation, surrogacy, Assisted Reproductive Technology (ART) procedures, etc. They assist infertile couples, single parents and members of the LGBT community to plan a family.

The expanding career-oriented population base has led to the increasing prevalence of delayed pregnancies, which is contributing significantly to the market growth. Owing to concerns such as expensive childcare services, academic or career ambitions, and a lack of financial stability, people often opt to have children late in life when they are more mature and financially established. However, excessive workload and the accompanying stress along with sedentary lifestyle habits including smoking and consumption of drugs lead to infertility issues among many of them. Moreover, the rising prevalence of various medical ailments such as endometrial tuberculosis, polycystic ovarian syndrome (PCOS) and sexually transmitted diseases (STDs) that can cause infertility, is also projected to catalyze the growth of the market. Additionally, growing awareness among individuals and increasing accessibility to improved healthcare facilities have further increased the adoption of these services in both developed and emerging economies. Other factors such as increasing advertising and promotion of fertility services on televisions and online portals along with the rising disposable incomes and flexible coverage offered by health insurance companies are also augmenting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global fertility services market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on cause of infertility, procedure, service, and end-user.

Breakup by Cause of Infertility:

Male Infertility

Female Infertility

Breakup by Procedure:

In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)

Surrogacy

In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)

Intrauterine Insemination (IUI)

Others

Breakup by Service:

Fresh Non-Donor

Frozen Non-Donor

Egg and Embryo Banking

Fresh Donor

Frozen Donor

Breakup by End-User:

Fertility Clinics

Hospitals

Surgical Centres

Clinical Research Institutes

Cryobanks

Breakup by Region:

Europe

North America

Asia Pacific

Middle East and Africa

Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Instituto Bernabeu Group, INVO Bioscience, Inc., Monash IVF Group, Apollo Hospitals Enterprise Ltd., CARE Fertility Group Ltd., Carolinas Fertility Institute, Genea Limited, The Cooper Companies, Inc., Virtus Health Group, Vitrolife Sweden AB, The Johns Hopkins Health System Corporation, Medicover AB (publ), OvaScience, Inc., Progyny, Inc., and Xytex Corporation.

IMARC Group's latest report provides a deep insight into the global fertility services market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the fertility services market in any manner.

Key Questions Answered in This Report

• 1. What was the size of the global fertility services market in 2023?
• 2. What is the expected growth rate of the global fertility services market during 2024-2032?
• 3. What has been the impact of COVID-19 on the global fertility services market?
• 4. What are the key factors driving the global fertility services market?
• 5. What is the breakup of the global fertility services market based on the cause of infertility?
• 6. What is the breakup of the global fertility services market based on the procedure?
• 7. What is the breakup of the global fertility services market based on the service?
• 8. What is the breakup of the global fertility services market based on the end-user?
• 9. What are the key regions in the global fertility services market?
• 10. Who are the key players/companies in the global fertility services market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Fertility Services Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Cause of Infertility
• 5.5 Market Breakup by Procedure
• 5.6 Market Breakup by Service
• 5.7 Market Breakup by End-User
• 5.8 Market Breakup by Region
• 5.9 Market Forecast

6 Market Breakup by Cause of Infertility

• 6.1 Male Infertility
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Female Infertility
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Procedure

• 7.1 In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Surrogacy
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Intrauterine Insemination (IUI)
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Service

• 8.1 Fresh Non-Donor
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Frozen Non-Donor
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Egg and Embryo Banking
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Fresh Donor
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Frozen Donor
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End-User

• 9.1 Fertility Clinics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Hospitals
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Surgical Centres
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Clinical Research Institutes
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Cryobanks
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Market Breakup by Region

• 10.1 Europe
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 North America
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Asia Pacific
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Middle East and Africa
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Latin America
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Instituto Bernabeu Group
  • 15.3.2 INVO Bioscience, Inc.
  • 15.3.3 Monash IVF Group
  • 15.3.4 Apollo Hospitals Enterprise Ltd.
  • 15.3.5 CARE Fertility Group Ltd.
  • 15.3.6 Carolinas Fertility Institute
  • 15.3.7 Genea Limited
  • 15.3.8 The Cooper Companies, Inc.
  • 15.3.9 Virtus Health Group
  • 15.3.10 Vitrolife Sweden AB
  • 15.3.11 The Johns Hopkins Health System Corporation
  • 15.3.12 Medicover AB (publ)
  • 15.3.13 OvaScience, Inc.
  • 15.3.14 Progyny, Inc.
  • 15.3.15 Xytex Corporation